Research
July 28, 2021
UAMS Research Looks at Arkansans’ Preferred COVID-19 Testing Sites, Reasons for Not Getting Tested
FAYETTEVILLE – Two studies by researchers at the University of Arkansas for Medical Sciences (UAMS) have shed some light on Arkansans’ preferred locations for COVID-19 testing and the reasons why some people may decide not to get a test in the first place. “Due to the recent surge in COVID-19 cases and hospitalizations in Arkansas,…
July 21, 2021
Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team
LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…
July 20, 2021
UAMS Releases Findings from Statewide COVID-19 Antibody Study
LITTLE ROCK — A statewide COVID-19 antibody study led by UAMS found that by the end of 2020, 7.4% of Arkansans had antibodies to the virus, but there were wide disparities among racial and ethnic groups. UAMS researchers released their findings this week to a public database, medRxiv (med archive).
July 14, 2021
NIH Awards $1.36 million Grant to Aid UAMS Research on Pregnant Women’s Pelvic Floor Muscles
The National Institutes of Health has awarded a $1.36 million grant to researchers at UAMS to develop a non-invasive means of detecting weaknesses in a pregnant woman’s pelvic floor muscles that could lead to injury while giving birth.
July 9, 2021
UAMS Medical Student Published in JAMA Network Open
The Journal of the American Medical Association (JAMA) recently published University of Arkansas for Medical Sciences (UAMS) medical student Austin Morgan’s results from his study on diversity among cancer centers’ leadership.
July 7, 2021
Researcher Finds Challenges in Study Involving Methamphetamine
If the photo of the pile of crystal methamphetamine doesn’t get your attention, the question on the flyer, designed by the UAMS Translational Research Institute and complete with the UAMS logo and familiar triangles, will.
“Use meth?”
July 6, 2021
Winthrop P. Rockefeller Cancer Institute Hosts First Summer Research Intensive for Medical Students
New discoveries in cancer treatment might come from 24-year-old Nadia Safar, one of 12 UAMS medical students participating in the state’s first and only undergraduate cancer research program at the Winthrop P. Rockefeller Cancer Institute.
July 1, 2021
UAMS Neurologist Co-Authors Best Practices Paper for Treating 2 Parkinson’s-related Disorders
LITTLE ROCK — A neurologist at the University of Arkansas for Medical Sciences (UAMS) has co-authored a paper in a leading neurology journal that provides the first best-practices consensus for treating two rare Parkinson’s-related disorders. Rohit Dhall, M.D., a professor of neurology in the College of Medicine and director of neurodegenerative disorders at UAMS, was…
June 29, 2021
UAMS Physicians See Dramatic Increase In Postpartum Psychosis Cases during COVID-19 Pandemic
LITTLE ROCK — Postpartum psychosis is a serious, albeit rare illness, compared to the number of postpartum depression cases seen in the United States.
June 24, 2021
UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer
LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…
Next page